Delivery Order SPE2DB20D1100-SPE2DB24FD5M0

Award Date 8/29/24
Potential Completion Date 8/30/24
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. The contract has a ceiling value of $10,391.27 and is a firm fixed price type contract, with a performance period through May 15, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. The contract is a firm-fixed-price delivery order, with a ceiling value of $2,994.90 and a period of performance through November 7, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, with a ceiling value of $3,676.85. The contract is a firm fixed-price, non-set-aside award with a completion date of May 19, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,647.48, is for the supply of AIMOVIG 140 MG/ML autoinjectors. It is a firm fixed-price contract with a completion date of February 20, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract has a ceiling value of $5,162.97 and an ultimate completion date of August 12, 2024. The contract is a firm-fixed-price delivery order, without any set-aside designation. AmerisourceBergen, as the prime contractor, will be responsible for providing the specified pharmaceutical item to support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AIMOVIG 70 MG/ML AUTOINJECTORML, a pharmaceutical product, with a ceiling value of $1,017.46. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, with a ceiling value of $2,035.16 and a performance period ending on June 13, 2025. The contract is a firm-fixed-price delivery order, and there is no set-aside designation, indicating open competition. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty medication, with a ceiling value of $5,488.23 and a period of performance through April 1, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AIMOVIG 70 MG/ML AUTOINJECTORML, a medication, with a ceiling value of $2,034.92 and a completion date of May 29, 2025. The contract is a firm fixed-price arrangement without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the provision of the pharmaceutical product Aimovig 70 mg/ml autoinjector. The contract has a ceiling value of $5,606.51 and a completion date of May 23, 2024. AmerisourceBergen, a major pharmaceutical distribution company, is the prime contractor for this delivery order, which is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with DLA Troop...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD5M0
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML pharmaceutical product. The contract has a ceiling value of $2,891.64 and is a firm fixed price delivery order. There is no set-aside designation for this award. AmerisourceBergen, a large pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation to provide a wide range of medical commodities, including prescription drugs and supplies, to support federal healthcare programs and facilities. This specific delivery order is part of the DLA Troop Support Medical IDC, which has a total potential value of up to $999,999,999 through December 2025.

Generated 11/28/24, 9:31 AM